Coherus Provides Updates on Clinical Studies By: Benzinga via Benzinga September 03, 2015 at 16:03 PM EDT Coherus BioSciences, Inc. (NASDAQ: CHRS), a leading pure-play, global biosimilars company with late-stage clinical products, today ... Read More >> Related Stocks: Coherus Bio